Skip to content

Improving gait stability; the effect of step length and step frequency manipulations on the margins of stability in stroke patients.;Amendement on: Evaluating the risk of falling during gait: Which strategies do stroke-patients and transtibial amputees use to maintain dynamic stability and gait adaptability?

Improving gait stability; the effect of step length and step frequency manipulations on the margins of stability in stroke patients.;Amendement on: Evaluating the risk of falling during gait: Which strategies do stroke-patients and transtibial amputees use to maintain dynamic stability and gait adaptability? - Evaluating the risk of falling during gait

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39137
Enrollment
10
Registered
2011-12-22
Start date
2012-04-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CVA Stroke

Interventions

None listed

Sponsors

Vrije Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Able to walk independently in daily life without help of any walking assistive device (Stroke patients: minimal FAC 4; Amputees: minimal SIGAM D)

Exclusion criteria

Exclusion criteria: - cognitive or communicative disorders that can affect the protocol (Mini Mental State Examination >= 24), - visual impairments that can affect the protocol - attention impairments that can affect the protocol - severe cardiovascular diseases that contra indicate moderately intense exercise - other co-morbidities that could affect balance control or energy expenditure during walking - medication that could interfere with balance control or energy expenditure during walking.

Design outcomes

Primary

MeasureTime frame
- Walking speed - Step length - Step frequency - Step width AMENDEMENT - additional outcome measure: - Sideward and backward margins of stability

Secondary

MeasureTime frame
N.A.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)